<progress id="397nd"></progress>

<progress id="397nd"></progress>

<progress id="397nd"><meter id="397nd"><mark id="397nd"></mark></meter></progress><progress id="397nd"><meter id="397nd"><mark id="397nd"></mark></meter></progress>

<big id="397nd"></big>

<noframes id="397nd"><em id="397nd"><strike id="397nd"></strike></em>

<progress id="397nd"></progress>

<big id="397nd"><meter id="397nd"></meter></big>

<big id="397nd"><progress id="397nd"><mark id="397nd"></mark></progress></big>

<big id="397nd"></big>

<progress id="397nd"></progress>

<big id="397nd"></big>

<big id="397nd"><progress id="397nd"><meter id="397nd"></meter></progress></big>

<meter id="397nd"></meter>

<big id="397nd"><meter id="397nd"></meter></big><big id="397nd"></big><big id="397nd"></big><progress id="397nd"><meter id="397nd"><mark id="397nd"></mark></meter></progress>

<progress id="397nd"></progress><progress id="397nd"><meter id="397nd"><mark id="397nd"></mark></meter></progress>

<progress id="397nd"></progress>

<progress id="397nd"></progress><meter id="397nd"></meter>

<progress id="397nd"></progress>

<big id="397nd"><progress id="397nd"></progress></big>

<big id="397nd"></big><progress id="397nd"></progress><progress id="397nd"><meter id="397nd"><menuitem id="397nd"></menuitem></meter></progress>

<big id="397nd"></big>

<progress id="397nd"><menuitem id="397nd"><mark id="397nd"></mark></menuitem></progress>

<meter id="397nd"></meter>

<progress id="397nd"><menuitem id="397nd"></menuitem></progress>

<progress id="397nd"><meter id="397nd"></meter></progress>

<big id="397nd"></big>

<big id="397nd"><meter id="397nd"></meter></big>

<progress id="397nd"></progress>

<progress id="397nd"><menuitem id="397nd"><ins id="397nd"></ins></menuitem></progress><big id="397nd"></big><meter id="397nd"></meter><meter id="397nd"><menuitem id="397nd"><ins id="397nd"></ins></menuitem></meter>

嚴格的產品驗證

首家發表NGS大panel驗證文章的中國精準診療公司

總計納入33個細胞系及3309例臨床樣本

  1. 這是國際首篇同時驗證靶向治療和免疫治療生物標志物(TMB&MSI)的NGS大panel的文章
  2. 在全流程質控體系下,至本秉持行業最高標準,對各系列產品進行系統化的驗證
  3. 確保每一位患者的檢測得到最精確的結果,為醫生的臨床治療決策提供堅強后盾
了解詳情 >

國內首家與FMI大panel檢測產品
進行“頭對頭”研究的中國精準診療公司

  1. 發表于國際腫瘤臨床專業期刊JCO Precision Oncology(ASCO官方刊物)
  2. 該“頭對頭”比較研究系國內首個與FDA獲批大panel產品在同一樣本上的對照研究。結果顯示,至本的大panel檢測產品與Foundation Medicine旗下獲得FDA審批的F1CDx檢測產品在所對照的多個基因、不同變異形式上均保持高度的一致性
了解詳情 >
18禁无遮挡羞羞污污污污网站